RPFG yields 125000.00% · ABBV yields 3.06%● Live data
📍 RPFG pulled ahead of the other in Year 1
Combined, RPFG + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RPFG + ABBV for your $10,000?
Rainier Pacific Financial Group Inc. operates as the holding company for Rainier Pacific Savings Bank, which provides various banking services. Its deposit products include checking accounts, money market deposit accounts, savings accounts, certificates of deposit, and individual retirement accounts. The company's lending products include one-to-four family, multifamily, and commercial real estate loans; real estate construction loans, such as residential construction loans, single family land acquisition and development loans, and lot inventory loans; and consumer installment loans, such as auto, boats, recreational, home equity, and personal loans, as well as unsecured personal lines of credit, home equity lines of credit, and credit cards. In addition, it provides automobile and homeowners' insurance, financial planning, and non-federally insured mutual fund and investment services. The company provides its services to consumers, small and medium-sized businesses, and professionals. As of June 30, 2009, it operated 14 branch offices in the Tacoma-Pierce County market and the City of Federal Way, Washington State. The company was founded in 1932 and is based in Tacoma, Washington.
Full RPFG Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.